Management of benign prostatic hyperplasia. Alternatives to standard therapy.
Benign prostatic hyperplasia is a significant cause of morbidity in the elderly male population. The standard therapy for symptomatic prostatic obstruction has been prostatectomy by transurethral resection (TURP) or, less frequently, by open surgery. Innovative alternative treatments of benign prostatic hyperplasia, both surgical and nonsurgical, will be discussed. Additionally, an appraisal of TURP will be made.
Silverstein
J I
JI
Department of Urology, Long Island Jewish Medical Center, New Hyde Park, New York.
Badlani
G H
GH
Smith
A D
AD
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011468:Prostatectomy / Q000009:adverse effects / Q000379:methods / Q000401:mortality; D011470:Prostatic Hyperplasia / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery*
D000317:Adrenergic alpha-Antagonists; D000726:Androgen Antagonists